Trials / Completed
CompletedNCT01743729
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Currently Using Artificial Tears (OPUS-2)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 720 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the safety and efficacy of lifitegrast ophthalmic solution compared to placebo in the treatment of dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lifitegrast | Lifitegrast Ophthalmic Solution 5.0% |
| DRUG | Placebo | Placebo for Lifitegrast Ophthalmic Solution 5.0% |
Timeline
- Start date
- 2012-12-07
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2012-12-06
- Last updated
- 2021-06-23
- Results posted
- 2017-02-24
Locations
31 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01743729. Inclusion in this directory is not an endorsement.